Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo

References

• Acker B., Lentle B., Chaplin D. J. 1987, The effect of hydralazine (apresoline) on blood flow in human tumours. Abstr. E43–8P. 8th International Congress of Radiation Research, Edinburgh, U.K.
   Google Scholar
• Algire G. H., Legallais F. Y., Anderson B. F. Vascular reactions of normal and malignant tissues in vivo. VI. The role of hypotension in the action of components of podophyllin on transplanted sarcomas. Journal of the National Cancer Institute 1954; 14: 879–893
   PubMedGoogle Scholar
• Babbs C. F., DeWitt D. P., Voorhees W. D., McCaw J. S., Chan R. C. Theoretical feasibility of vasodilator-enhanced local tumour heating. European Journal of Cancer Clinical Oncology 1982; 18: 1137–1146
   PubMedGoogle Scholar
• Brown J. M., Horsman M. R., Zeman E. M., Hirst V. K., Lemmon M. L. Enhancement of tumor cell toxicity by SR 4233 with hydralazine. EdinburghUK, 1987, Abstr. E43–7P, 8th International Congress of Radiation Research
   Google Scholar
• Cater D. B., Grigson C. M. B., Watkinson D. A. Changes of oxygen tension in tumors induced by vasoconstrictor and vasodilator drugs. Acta Radiologica 1962; 58: 401–408
   PubMed Web of Science ®Google Scholar
• Chan R. C., Babbs C. F., Vetter R. J., Lamar C. H. Abnormal response of tumor vasculature to vasoactive drugs. Journal of the National Cancer Institute 1984; 72: 145–150
   PubMed Web of Science ®Google Scholar
• Chaplin D. J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. International Journal of Radiation Oncology, Biology, and Physics 1987; 13: 579–585
   PubMed Web of Science ®Google Scholar
• Dewey W. C., Thrall D. E., Gillette E. L. Hyperthermia and radiation-a selective thermal effect on chronically hypoxic tumor cells in vivo. International Journal of Radiation Oncology, Biology, and Physics 1977; 2: 99–103
   PubMed Web of Science ®Google Scholar
• Eddy H. A., Casarett G. W. Development of the vascular system in the hamster malignant neurilemmoma. Microvascular Research 1973; 6: 63–82
   PubMed Web of Science ®Google Scholar
• Folkman J. The vascularization of tumors. Scientific American 1976; 234: 58–73
   PubMed Web of Science ®Google Scholar
• Gerweck L. E., Gillette E. L., Dewey W. C. Killing of Chinese hamster cells in vitro by heating under hypoxic or aerobic conditions. European Journal of Cancer 1974; 10: 691–693
   PubMed Web of Science ®Google Scholar
• Gerweck L. E., Nygaard T. G., Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Research 1979; 39: 966–972
   PubMed Web of Science ®Google Scholar
• Gillette E. L. Experimental studies of tumor response to hyperthermia alone or combined with other modalities, J. Overgaard. Taylor & Francis, London 1985; 71–90, Hyperthermic Oncology 1984, Vol. 2: Review Lectures, Symposium Summaries and Workshop Summaries
   Google Scholar
• Hahn G. M. Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Research 1974; 34: 3117–3123
   PubMed Web of Science ®Google Scholar
• Hill S. A., Denekamp J. The effect of vascular occlusion on the thermal sensitization of a mouse tumour. British Journal of Radiology 1978; 51: 997–1002
   PubMed Web of Science ®Google Scholar
• Kamura T., Nielsen O. S., Overgaard J., Andersen A. H. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo. Cancer Research 1982; 42: 1744–1748
   PubMed Web of Science ®Google Scholar
• Kruuv J. A., Inch W. R., McCredie J. A. Blood flow and oxygenation of tumour in mice. II. Effect of vasodilator drugs. Cancer 1967; 20: 60–65
   PubMed Web of Science ®Google Scholar
• Leier C. V., Magorian R. D., Desch C. E., Thomson M. J., Unveferth D. V. Hydralazine and isosorbide dinitrate comparative regional hemodynamic effects when administered alone or in combination. Circulation 1981; 63: 102–109
   PubMed Web of Science ®Google Scholar
• Lindegaard J. C., Overgaard J. Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo. International Journal of Hyperthermia 1987; 3: 79–91
   PubMed Web of Science ®Google Scholar
• Nielsen O. S. Effect of fractionated hyperthermia on hypoxic cells in vitro. International Journal of Radiation Biology 1981; 39: 73–80
   Web of Science ®Google Scholar
• Mickerson M. Vasodilator drugs. The Pharmacological Basis of Therapeutics, 5th edn, L. S. Goodman, A. Gilman. Macmillan, New York 1975; 727–743
   Google Scholar
• Nickerson M., Ruedy J. Antihypertensive agents and the drug therapy of hypertension. Pharmacological Basis of Therapeutics, 5th edn, L. S. Goodman, A. Gilman. Macmillan, New York 1975; 705–726
   Google Scholar
• Nussbaum G. H., Babbs C. F., Mintun M. A. Results of a preliminary study of the potential of vasodilators for improving thermotherapy of deep-seated tumors. International Journal of Hyperthermia 1986; 2: 61–64
   PubMedGoogle Scholar
• Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. International Journal of Radiation Oncology, Biology, and Physics 1980; 6: 1507–1517
   PubMed Web of Science ®Google Scholar
• Overgaard J. The effect of hyperthermia on the hypoxic fraction in an experimental mammary carcinoma in vivo. British Journal of Radiology 1981; 54: 245–249
   PubMed Web of Science ®Google Scholar
• Overgaard J., Bichel P. The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro. Radiology 1977; 123: 511–514
   PubMed Web of Science ®Google Scholar
• Overgaard J., Nielsen O. S. The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. Annals of the New York Academy of Science 1980; 335: 254–280
   PubMedGoogle Scholar
• Power J. A., Harris J. W. Response of extremely hypoxic cells to hyperthermia: survival and oxygen enhancement ratios. Radiation Biology 1977; 123: 767–770
   Google Scholar
• Sapirstein L. A. Regional blood flow by fractional distribution of indicators. American Journal of Physiology 1958; 193: 161–168
   PubMed Web of Science ®Google Scholar
• Suit H. D. Hyperthermia in the treatment of tumours. Proceedings of the International Symposium on Cancer Therapy by Hyperthermia and Radiation, Washington, 28–30 April. American College of Radiology, 1975; 107–114
   Google Scholar
• Suit H. D., Gerweck L. E. Potential for hyperthermia and radiation therapy. Cancer Research 1979; 39: 2290–2298
   PubMed Web of Science ®Google Scholar
• Sutton F. J. Vasodilator therapy. American Journal of Medicine 1986; 80: 54–58
   Google Scholar
• Thrall D. E., Gillette E. L., Dewey W. C. Effect of heat and ionizing radiation on normal and neoplastic tissue of the C3H mouse. Radiation Research 1975; 63: 363–377
   PubMed Web of Science ®Google Scholar
• Tobari C., Van Kersen I., Hahn G. Effect of hydralazine or glucose on the pH of tumors and of several normal tissues. Abstr. Ab-2, Radiation Research Society Meeting, Las Vegas, Nevada, 1986
   Google Scholar
• Vaupel P. Interrelationship between mean arterial blood flow and vascular resistance in solid tumor tissue of DS-carcino-sarcoma. Experientia 1975; 31: 587
   PubMedGoogle Scholar
• Vorhees W. D., Babbs C. F. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. European Journal of Cancer Clinical Oncology 1982; 19: 1027–1033
   Google Scholar
• Voorhees W. D., Richardson R. C. Vasodilator enhanced hyperthermia therapy: A veterinary clinical study. Abstr. Bf-3, Radiation Research Society Meeting, Las Vegas, Nevada, 1986
   Google Scholar
• Wallen C. A., Colby T. V., Stewart J. R. Cell kill and tumour control after heat treatment with and without vascular occlusion in RIF-1 tumors. Radiation Research 1986; 106: 215–223
   PubMed Web of Science ®Google Scholar